Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIT: 2010-2012

Historic EBIT for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$680,000.

  • Sonoma Pharmaceuticals' EBIT rose 71.11% to -$680,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$3.5 million, marking a year-over-year increase of 45.88%. This contributed to the annual value of -$6.5 million for FY2012, which is 13.83% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported EBIT of -$680,000 as of Q4 2012, which was up 16.77% from -$817,000 recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year EBIT high stood at -$495,000 for Q2 2012, and its period low was -$2.4 million during Q2 2010.
  • Moreover, its 3-year median value for EBIT was -$1.5 million (2012), whereas its average is -$1.5 million.
  • Within the past 5 years, the most significant YoY rise in Sonoma Pharmaceuticals' EBIT was 75.47% (2012), while the steepest drop was 29.68% (2012).
  • Over the past 3 years, Sonoma Pharmaceuticals' EBIT (Quarterly) stood at -$2.1 million in 2010, then decreased by 13.28% to -$2.4 million in 2011, then soared by 71.11% to -$680,000 in 2012.
  • Its last three reported values are -$680,000 in Q4 2012, -$817,000 for Q3 2012, and -$495,000 during Q2 2012.